FMP
Enter
API Tools
Extras
Regencell Bioscience Holdings Limited
RGC
NASDAQ
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
12.62 USD
-1.47 (-11.65%)
Build Up Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
-
-
-
-
-
-
-
-
-
-
Operating Cash Flow
-726.57k
-767.31k
-5.27M
-4.96M
-4M
-
-
-
-
-
Cap Ex
-117.84k
-
-780.88k
-27.39k
-5.38k
-
-
-
-
-
Free Cash Flow
-844.41k
-767.31k
-6.05M
-4.99M
-4.01M
-
-
-
-
-
Wacc
5.03
5.03
5.03
5.03
5.03
Pv Lfcf
-
-
-
-
-
Sum Pv Lfcf
-
